GET THE APP

Process for producing 6-(2, 3-dichlorophenyl)-1, 2, 4-triazine 3,5-diamine (Lamotrigine) and identification, characterization of a new N-methyl impurity | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Process for producing 6-(2, 3-dichlorophenyl)-1, 2, 4-triazine 3,5-diamine (Lamotrigine) and identification, characterization of a new N-methyl impurity

Author(s): G. Venkanna, D. Nagender, P. Venkateswarlu, K. Chandra Shekhar, G. Madhusudhan and K. Mukkanti

Disclosed herein is the industrial scalable process for producing the 6-(2,3-dichloro-phenyl)- 1,2,4-triazine-3,5-diamine (Lamotrigine) with 99.9% HPLC purity and high yield in neutral conditions as compared to basic and acidic reaction conditions. The major impurities, A, B, C, D, E, F and G, are listed in European & US pharmacopoeias. We are reporting, an investigated and characterized new impurity (N-methyl impurity) and besides a way to control during the process.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry